Moreover, multiplex Immunohistochemistry (IHC) staining with confocal imagining confirmed the p‐RUNX1+ TAMs were undergoing MMT in NSCLC, suggested by their strong expression of CAF marker α‐SMA (Figure 2B). The gene discussed is RUNX1; the disease is non-small cell lung carcinoma.